Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.270
-0.230 (-6.57%)
At close: Feb 27, 2026, 4:00 PM EST
3.200
-0.070 (-2.14%)
After-hours: Feb 27, 2026, 7:41 PM EST
Apyx Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Apyx Medical stock have an average target of 7.00, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts an increase of 114.07% from the current stock price of 3.27.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 16, 2025.
Analyst Ratings
The average analyst rating for Apyx Medical stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth Capital | Roth Capital | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +83.49% | Dec 16, 2025 |
| Citizens | Citizens | Hold → Buy Upgrades $8 | Hold → Buy | Upgrades | $8 | +144.65% | Nov 12, 2025 |
| BTIG | BTIG | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 17, 2024 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +52.91% | Nov 10, 2023 |
Financial Forecast
Revenue This Year
52.61M
from 48.10M
Increased by 9.36%
Revenue Next Year
56.13M
from 52.61M
Increased by 6.70%
EPS This Year
-0.32
from -0.66
EPS Next Year
-0.37
from -0.32
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 55.4M | 60.9M | ||||
| Avg | 52.6M | 56.1M | ||||
| Low | 49.8M | 51.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 15.3% | 15.8% | ||||
| Avg | 9.4% | 6.7% | ||||
| Low | 3.5% | -2.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.30 | -0.32 | |
| Avg | -0.32 | -0.37 | |
| Low | -0.32 | -0.41 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.